# Filing Detail

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001213900-22-074049
Filing Date
2022-11-21
Accepted
2022-11-21 09:44:55
Documents
99
Period of Report
2022-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | AMENDMENT NO. 1 TO FORM 10-Q | f10q0322a1_immucell.htm iXBRL | 10-Q/A | 1092855
2 | CERTIFICATION | f10q0322a1ex31_immucell.htm | EX-31 | 9896
3 | CERTIFICATION | f10q0322a1ex32_immucell.htm | EX-32 | 4992
| Complete submission text file | 0001213900-22-074049.txt |  | 7184425

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL SCHEMA FILE | iccc-20220331.xsd | EX-101.SCH | 94211
5 | XBRL CALCULATION FILE | iccc-20220331_cal.xml | EX-101.CAL | 26922
6 | XBRL DEFINITION FILE | iccc-20220331_def.xml | EX-101.DEF | 340431
7 | XBRL LABEL FILE | iccc-20220331_lab.xml | EX-101.LAB | 661930
8 | XBRL PRESENTATION FILE | iccc-20220331_pre.xml | EX-101.PRE | 360210
93 | EXTRACTED XBRL INSTANCE DOCUMENT | f10q0322a1_immucell_htm.xml | XML | 1042566

Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-12934 | Film No.: 221403795
SIC: 2835 In Vitro & In Vivo Diagnostic Substances